Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Title Grant Type Focus Area Country Application Due Date Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA Project to Evaluate the Effectiveness of Elranatamab in the Treatment of Multiple MyelomaRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA Approaches to Increase Equitable Access to and Delivery of Quality of Care with BsAb for Patients with Mutiple MyelomaRelease Date:Partner: International Myeloma FoundationQuality Improvement Oncology All Improving the care and outcomes of Canadians living with metastatic NSCLCRelease Date:Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung AssociationQuality Improvement Oncology Canada Committing to Support Elderly Cancer PatientsRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Establishing System for Early Detection of Atrial Fibrillation and Prevention of Cardioembolic StrokeRelease Date:Quality Improvement Internal Medicine Japan Improving Early Detection and Appropriate Anticoagulant Therapy for Atrial FibrillationRelease Date:Education Internal Medicine Japan Promoting Understanding of Maternal ImmunizationRelease Date:Education Vaccines Japan Promoting Understanding of Pneumonia PreventionRelease Date:Education Vaccines Japan Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid CardiomyopathyRelease Date:Education Rare Disease USA Treatment Environment of Appropriate antiviral therapy for COVID-19 InfectionsRelease Date:Education Hospital Japan